Is Sotorasib available in the country?

Sotorasib (Sotorasib) is a new type of drug for the treatment of non-small cell lung cancer and other diseases. It was approved by the U.S. Food and Drug Administration (FDA) in May 2021. It has not yet been launched in China, so it is not covered by medical insurance. Domestic patients cannot yet purchase this drug. The price of Hong Kong original research versionsotorasibuSpecifications120mg*240 tablets is about RMB 80,000, and the European original research version 120mg*240 tablets is priced at about RMB 44,040 (the price may fluctuate due to the exchange rate), which is relatively expensive. There are also cheaper generic drugs for sale in other countries. The price of 120mg*56 tablets produced by Laos Element Pharmaceuticals is around 4800 RMB (the price may fluctuate due to the exchange rate), and the price is relatively cheap.